Although our previous study revealed that SOX-17 expression is operated by CX3CR1-mediated PR activation, the action of FKN on SOX-17 protein expression is controversial in anemia, probably due to the altered level of progesterone in a serum-free medium. The gene discussed is CX3CL1; the disease is anemia.